Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9467 |
High Similarity |
NPD2801 |
Approved |
0.9404 |
High Similarity |
NPD3817 |
Phase 2 |
0.9388 |
High Similarity |
NPD1512 |
Approved |
0.9342 |
High Similarity |
NPD3882 |
Suspended |
0.9272 |
High Similarity |
NPD1934 |
Approved |
0.9252 |
High Similarity |
NPD1511 |
Approved |
0.9172 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9172 |
High Similarity |
NPD6166 |
Phase 2 |
0.9172 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9085 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9006 |
High Similarity |
NPD6797 |
Phase 2 |
0.8951 |
High Similarity |
NPD7251 |
Discontinued |
0.8933 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8896 |
High Similarity |
NPD7808 |
Phase 3 |
0.8896 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD7054 |
Approved |
0.8827 |
High Similarity |
NPD7472 |
Approved |
0.882 |
High Similarity |
NPD3818 |
Discontinued |
0.8712 |
High Similarity |
NPD7074 |
Phase 3 |
0.8671 |
High Similarity |
NPD7075 |
Discontinued |
0.8618 |
High Similarity |
NPD6799 |
Approved |
0.8608 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8535 |
High Similarity |
NPD6801 |
Discontinued |
0.8526 |
High Similarity |
NPD4380 |
Phase 2 |
0.8481 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8428 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8424 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8291 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8289 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD2796 |
Approved |
0.825 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8221 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8205 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8188 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD1247 |
Approved |
0.817 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD919 |
Approved |
0.8137 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8086 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8067 |
Intermediate Similarity |
NPD943 |
Approved |
0.8061 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7973 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7882 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7875 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7778 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7748 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7706 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD2533 |
Approved |
0.764 |
Intermediate Similarity |
NPD2532 |
Approved |
0.764 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7633 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6099 |
Approved |
0.758 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7548 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7547 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD3748 |
Approved |
0.75 |
Intermediate Similarity |
NPD9494 |
Approved |
0.75 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7459 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7444 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD920 |
Approved |
0.7425 |
Intermediate Similarity |
NPD37 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7396 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7396 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7396 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7338 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7296 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7239 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7219 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.709 |
Intermediate Similarity |
NPD6779 |
Approved |
0.709 |
Intermediate Similarity |
NPD6782 |
Approved |
0.709 |
Intermediate Similarity |
NPD6781 |
Approved |
0.709 |
Intermediate Similarity |
NPD6777 |
Approved |
0.709 |
Intermediate Similarity |
NPD6776 |
Approved |
0.709 |
Intermediate Similarity |
NPD6778 |
Approved |
0.709 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7072 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7072 |
Intermediate Similarity |
NPD8313 |
Approved |
0.707 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7049 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7025 |
Intermediate Similarity |
NPD411 |
Approved |
0.702 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7012 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.6994 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6981 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6968 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD228 |
Approved |
0.6936 |
Remote Similarity |
NPD4288 |
Approved |
0.6928 |
Remote Similarity |
NPD3887 |
Approved |
0.6923 |
Remote Similarity |
NPD3266 |
Approved |
0.6923 |
Remote Similarity |
NPD3267 |
Approved |
0.6893 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6891
|
Remote Similarity |
NPD7697 |
Approved |